BMRN
Price
$57.31
Change
-$1.06 (-1.82%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
11.19B
18 days until earnings call
FOLD
Price
$5.98
Change
-$0.31 (-4.93%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
1.94B
13 days until earnings call
Interact to see
Advertisement

BMRN vs FOLD

Header iconBMRN vs FOLD Comparison
Open Charts BMRN vs FOLDBanner chart's image
BioMarin Pharmaceutical
Price$57.31
Change-$1.06 (-1.82%)
Volume$42.3K
Capitalization11.19B
Amicus Therapeutics
Price$5.98
Change-$0.31 (-4.93%)
Volume$72.48K
Capitalization1.94B
BMRN vs FOLD Comparison Chart in %
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. FOLD commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and FOLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (BMRN: $58.37 vs. FOLD: $6.29)
Brand notoriety: BMRN and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 60% vs. FOLD: 108%
Market capitalization -- BMRN: $11.19B vs. FOLD: $1.94B
BMRN [@Biotechnology] is valued at $11.19B. FOLD’s [@Biotechnology] market capitalization is $1.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, both BMRN and FOLD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while FOLD’s TA Score has 5 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 5 bearish.
  • FOLD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BMRN and FOLD are a good buy in the short-term.

Price Growth

BMRN (@Biotechnology) experienced а -0.77% price change this week, while FOLD (@Biotechnology) price change was -0.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

BMRN is expected to report earnings on Oct 22, 2025.

FOLD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($11.2B) has a higher market cap than FOLD($1.94B). BMRN YTD gains are higher at: -11.197 vs. FOLD (-33.227). BMRN has higher annual earnings (EBITDA): 777M vs. FOLD (53.6M). BMRN has more cash in the bank: 1.27B vs. FOLD (251M). FOLD has less debt than BMRN: FOLD (443M) vs BMRN (602M). BMRN has higher revenues than FOLD: BMRN (2.95B) vs FOLD (543M).
BMRNFOLDBMRN / FOLD
Capitalization11.2B1.94B578%
EBITDA777M53.6M1,450%
Gain YTD-11.197-33.22734%
P/E Ratio21.62N/A-
Revenue2.95B543M543%
Total Cash1.27B251M507%
Total Debt602M443M136%
FUNDAMENTALS RATINGS
BMRN vs FOLD: Fundamental Ratings
BMRN
FOLD
OUTLOOK RATING
1..100
1013
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7094
PRICE GROWTH RATING
1..100
6164
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (62) in the Biotechnology industry is in the same range as FOLD (63). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FOLD (100). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's SMR Rating (70) in the Biotechnology industry is in the same range as FOLD (94). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's Price Growth Rating (61) in the Biotechnology industry is in the same range as FOLD (64). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's P/E Growth Rating (99) in the Biotechnology industry is in the same range as FOLD (100). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNFOLD
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 10 days ago
58%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 8 days ago
63%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SUHCX21.66N/A
N/A
DWS Health and Wellness C
HGISX57.93N/A
N/A
Hartford Core Equity R4
MTCHX65.10N/A
N/A
MFS Technology R3
TVFVX65.29N/A
N/A
Third Avenue Value Investor
SUTAX16.33N/A
N/A
AB Sustainable US Thematic A